Shunya Arai

Years Active: 2018-2021
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Miyauchi Masashi, Yusuke Ito, Fumio Nakahara, Toshiya Hino, Fumi Nakamura, Yuki Iwasaki, Taiki Kawagoshi, Junji Koya, Akihide Yoshimi, Shunya Arai, Yuki Kagoya, Mineo Kurokawa
Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment. Blood (2021)
Masashi Miyauchi, Ken Sasaki, Yuki Kagoya, Kazuki Taoka, Yosuke Masamoto, Sho Yamazaki, Shunya Arai, Hideaki Mizuno, Mineo Kurokawa
CAMK2G is identified as a novel therapeutic target for myelofibrosis. Blood advances (2021)
Kensuke Takaoka, Masahito Kawazu, Junji Koya, Akihide Yoshimi, Yosuke Masamoto, Hiroaki Maki, Takashi Toya, Takashi Kobayashi, Yasuhito Nannya, Shunya Arai, Toshihide Ueno, Hironori Ueno, Kenshi Suzuki, Hironori Harada, Atsushi Manabe, Yasuhide Hayashi, Hiroyuki Mano, Mineo Kurokawa
A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination. Leukemia 33 (7) (2019)
Kensuke Matsuda, Akira Honda, Shunya Arai, Hiroaki Maki, Kumi Nakazaki, Mineo Kurokawa
Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease. Bone marrow transplantation 54 (2) (2018)
Masahiro Uni, Yosuke Masamoto, Tomohiko Sato, Yasuhiko Kamikubo, Shunya Arai, Eiji Hara, Mineo Kurokawa
Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification. Leukemia 33 (1) (2018)

Shunya Arai.css-eqlu8i{font-size:small;padding-left:4px;}